The Enteric Disease Testing Market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The increasing food demand has compelled farmers, food manufacturers, and suppliers to increase the quantity and improve the quality of agricultural produce and food products. To meet the increasing food demand, global food production must be increased by 70% by 2050, according to the Food and Agriculture Organization of the United Nations (FAO). The increase in global food production impacts the growth of the enteric disease testing market with an increasing number of enteric disease controls in each step—from the raw material procurement till the product reaches consumers, who look out for accredited certification when they purchase food products to ensure the safety of food.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139763313
Driver: Increase in demand for convenience foods
Busy lifestyles have slowly shifted consumer focus from traditional buying of raw food products to convenience and packaged food products, such as frozen foods and ready-to-eat (RTE) meals. For higher marketability, additives are used to accentuate the organoleptic characteristics of food & beverages. Packaged products are also added with preservatives to improve their shelf life. With the increase in preference for convenience foods, the need for enteric disease testing is growing.
The food segment is estimated to account for the fastest growth in the by end use segment for the enteric disease testing market.
The increase in food trade has encouraged public health and government agencies to continuously monitor food quality and take prompt actions to identify, contain, and correct sources of outbreaks. For instance, the Enteric disease and Inspection Service (FSIS) has framed regulations to control the contamination of meat & poultry products in slaughterhouses and processing plants, based on the HACCP enteric disease control system.
The meat, poultry and seafood food sub-segment is estimated to account for the largest market share in the by food end use segment of enteric disease testing market over the forecast period.
The global consumption of meat and processed meat products is highly rising. Further, with expanding globalization, food products are traded, which provides scope for various processes ranging from packaging, handling, storing and transportation, leading to food infestation. All these factors lead to an increased chance of contamination of the food, due to which the meat and seafood products are estimated to account for the highest market share in the market.
Make an Inquiry @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=139763313
The rising health awareness among consumers in the North American region and presence of key players is projected to account for the largest market size during the forecast period
The high level of awareness about healthy foods and nutrition is projected to drive the market growth for enteric disease testing market in North American region. Furthermore, the US and Canada combined have a high concentration of market players after Europe and are also high on technology adoption.
Key players in this market include SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Intertek Group plc (UK), Bureau Veritas (France), ALS Limited (Australia), and TÜV SÜD (Germany). Key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes in these regions. These companies have a strong presence in Europe and North America. They also have manufacturing facilities along with strong distribution networks across these regions.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/enteric-disease-testing-market-139763313.html